InsiderTrades.com logo
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

ASO Insider Trading

Insider Ownership Percentage: 33.25%
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Aston Minerals Insider Trading History Chart

This chart shows the insider buying and selling history at Aston Minerals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aston Minerals Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/28/2021 01:07 PM ET

This chart shows the closing price history over time for ASO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

Aston Minerals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/16/2023Russell BradfordInsiderIssued625,000A$0.04A$23,750.00
10/13/2023Russell BradfordInsiderIssued1,250,000A$0.06A$75,000.00
6/18/2021Tolga KumovaInsiderIssued30,000,000A$0.16A$4,650,000.00
5/27/2021Robert JewsonInsiderBuy20,000,000A$0.10A$2,000,000.00
See Full Table
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Aston Minerals (ASX:ASO)

4.64% of Aston Minerals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Aston Minerals logo
Aston Minerals Limited engages in the acquisition, exploration, and evaluation of mineral properties in Canada, Australia, Indonesia, and Europe. The company primarily explores for cobalt, nickel, copper, and gold deposits. It holds interest in the Edleston gold and nickel project located to the south of Timmins, Ontario. It has interests in the Dobsina Project in Slovakia; the Jouhineva Project in Finland; and the Swedish projects. Aston Minerals Limited was incorporated in 2010 and is based in Subiaco, Australia.
Read More on Aston Minerals

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

N/A

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.51

Who are the company insiders with the largest holdings of Aston Minerals?

Aston Minerals' top insider investors include:
  1. Russell Bradford (Insider)
Learn More about top insider investors at Aston Minerals.
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
From Autonomix   |   Ad
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.